This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Health Care Stocks Stumble on Trump's Executive Order
by Zacks Equity Research
Trump's executive order has sent jitters across the hospital sector that has been weighed down by a weak business environment also insurers remain unsure.
Molina Healthcare Appoints CEO: Will New Leadership Help?
by Zacks Equity Research
Molina Healthcare (MOH) appoints new CEO in an attempt to regain its lost glory.
How Molina Healthcare (MOH) Stock Stands Out in a Strong Industry?
by Zacks Equity Research
Molina Healthcare (MOH) is seeing solid earnings estimate revision activity, and is a great company from a Zacks Industry Rank perspective
Health Care Stocks in Focus as Repeal & Replace Gains Steam
by Zacks Equity Research
Healthcare stocks are jittery due to the regulatory uncertainty that the Graham-Cassidy bill may bring along.
Molina Healthcare (MOH) Up 5% Since Earnings Report: Can It Continue?
by Zacks Equity Research
Molina Healthcare (MOH) reported earnings about a month ago. What's next for the stock? We take a look at earnings estimates for some clues.
Molina Healthcare's Top Line Grows on Membership, Debts Hurt
by Zacks Equity Research
Molina Healthcare's (MOH) top line benefits from inorganic growth and membership. However, rising level of debt and expenses hurt margins.
Molina Healthcare (MOH) Incurs Loss in Q2, Revenues Beat
by Zacks Equity Research
Molina Healthcare (MOH) incurred loss in the second-quarter 2017 owing to higher medical care costs.
Healthcare Q2 Earnings Due on Aug 2: HUM, PRXL, MOH, TDOC
by Zacks Equity Research
The Medical sector is likely to benefit from inorganic growth, product launches, technology upgrades. However, regulatory hassles might offset its growth potential.
Centene's (CNC) Unit Secures Medicaid Contract in Mississipi
by Zacks Equity Research
The Mississippi subsidiary of Centene Corp. (CNC), Magnolia Health, will be serving Medicaid enrollees in the region. Medicaid is the state-federal program.
Senate Unveils Its Version of Trumpcare: Healthcare Stocks Up
by Arpita Dutt
Healthcare stocks were up yesterday following the release of the 142-page Better Care Reconciliation Act of 2017.
Why Investors Should Retain Molina Healthcare (MOH) Stock
by Zacks Equity Research
Molina Healthcare, Inc. (MOH) consistent operating performance is backed by its steady increase in premiums and service revenues, effective inorganic growth initiatives and solid fundamentals.
Zacks.com featured highlights: Ituran Location and Control, Molina Healthcare, WellCare Health Plans and Masimo
by Zacks Equity Research
Zacks.com featured highlights: Ituran Location and Control, Molina Healthcare, WellCare Health Plans and Masimo
Top Ranked Growth Stocks to Buy for May 11th
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, May 11th:
4 Top-Ranked Liquid Stocks for a Winning Portfolio
by Zacks Equity Research
Liquidity of a stock primarily indicates a company's capability to meet debt obligations by converting assets into liquid cash and equivalents.
Zacks.com featured highlights: Insight Enterprises, Molina Healthcare, Huntsman, Western Digital and AllianceBernstein Holding
by Zacks Equity Research
Zacks.com featured highlights: Insight Enterprises, Molina Healthcare, Huntsman, Western Digital and AllianceBernstein Holding
Molina Healthcare (MOH) Q4 Earnings, Revenues Beat Estimates
by Zacks Equity Research
Molina Healthcare Inc. (MOH) reported first-quarter 2017 adjusted net income per share of $1.47 that surpassed the Zacks Consensus Estimate of 57 cents by 157%.
Will Molina Healthcare (MOH) Continue to Surge Higher?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in Molina Healthcare, Inc. (MOH).
New Strong Sell Stocks for April 19th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
Another Run at Health Care Reform: Impact on Healthcare
by Zacks Equity Research
We wait to see how "repealing and replacing" the Obamacare with ACHC proceeds.
The Zacks Analyst Blog Highlights: HCA Holdings, Molina Healthcare, SPDR S&P Pharmaceuticals ETF, BioShares Biotechnology Products Fund and The Health Care Select Sector SPDR Fund
by Zacks Equity Research
The Zacks Analyst Blog Highlights: HCA Holdings, Molina Healthcare, SPDR S&P Pharmaceuticals ETF, BioShares Biotechnology Products Fund and The Health Care Select Sector SPDR Fund
Hospital Stocks Soar Upon the Death of TrumpCare
by Joseph Lu
While the Republican's unsuccessful attempt to repeal and replace the Affordable Care Act (ACA) was a disaster for the GOP, it was great news for hospital stocks like HCA Holdings (HCA) and Universal Health Service Inc. (UHS)
Cigna (CI) Trending Up in 2017: What's Driving the Stock?
by Zacks Equity Research
Shares of Cigna Corp. (CI) have significantly outperformed the Zacks categorized Health Maintenance Organization industry.
4 Reasons Why UnitedHealth (UNH) Stock Looks Attractive Now
by Zacks Equity Research
UnitedHealth Group Inc. (UNH) remains the leader in the health insurance industry by virtue of its vast scale and tremendously diversified operations.
Molina Hit by Public Exchanges, Failed Aetna-Humana Merger
by Zacks Equity Research
Molina Healthcare Inc. (MOH) continues to suffer from ongoing issues related to the Affordable Care Act's insurance Marketplace.
Why Is Molina Healthcare (MOH) Down 8.2% Since the Last Earnings Report?
by Zacks Equity Research
MOH reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.